Welcome back. It was a brutal week for the micro-cap space, where the bill finally came due for a handful of creative corporate structures. From a drone roll-up triggering cross-defaults with a major bank to a governance crisis that legally voided a board's existence, the theme this week is simple: eventually, you run out of borrowed time.
XTI Aerospace (XTIA): The Cross-Default Cascade
The Filing: XTI missed principal payments in September on $4.51 million of promissory notes issued to buy its drone businesses. That default immediately triggered a cross-default on a $20 million secured credit facility with JPMorgan Chase.
What Happened Next: XTI's holding company is now essentially at the mercy of its lenders. JPMorgan hasn't accelerated the $8.4 million it is currently owed, and XTI claims to have a temporary waiver in principle with the note sellers. The kicker? The interim CEO XTI appointed in August happens to hold an economic interest in the very sellers the company just defaulted on. XTI explicitly admits it lacks the liquidity to repay these obligations if accelerated. Handing the keys to an asset-based revolver is never a great look, and the stock is trading exactly as you'd expect.
Globaltek Ventures (ATVK): The Board That Wasn't
The Filing: Auditor Bansal & Co LLP resigned and issued a non-reliance notice covering every financial statement from 2019 through 2025.
What Happened Next: The auditor walked because Globaltek suffered a total breakdown of corporate governance. A court order found that previous leadership was improperly appointed. The company operated completely headless—without a single valid officer or director—from August 11 until a court intervened to appoint a custodian, Jacob Sherman, on October 12 to clean up the mess. You can't rely on the financials because, legally speaking, the people who signed them had no authority to do so.
Sangamo Therapeutics (SGMO): The $111 Million Bankruptcy Sale
The Filing: Sangamo filed its monthly operating report for August and confirmed its formal exit from Nasdaq to trade on the OTC Pink sheets as SGMOQ.
What Happened Next: Sangamo is bankrupt, but it isn't empty-handed. Since filing for Chapter 11 in June, the company managed to close a Section 363 sale of its Fabry disease gene therapy asset to PTC Therapeutics for $111 million in upfront cash and up to $100 million in milestones. It's a massive injection of liquidity for a debtor-in-possession, but common equity holders shouldn't get their hopes up. The company continues to explicitly warn that the stock price is highly speculative and will likely bear no relationship to any final recovery.
SITE Centers Corp. (SITC): Cashing Out and Clocking Out
The Filing: SITE Centers notified the NYSE that it is voluntarily delisting its common shares following the sale of its interests in the Dividend Trust Portfolio joint venture.
What Happened Next: This is a liquidation disguised as a delisting. Following the $32.4 million joint venture sale, SITE declared a massive $3.00 per share special dividend. With the stock trading around $3.50, the payout represents nearly the entire market capitalization of the company. Shares naturally jumped 19% on the announcement. Because the payout is so large, it would trigger an involuntary delisting anyway, so management is just beating the exchange to the punch. The remaining stub will vanish from the NYSE by December 4.
AmBase Corp (ABCP): The Litigation Stub
The Filing: AmBase took another $1.5 million in litigation funding from its own Chairman and CEO, Richard Bianco, slapping another going concern warning on the tape.
What Happened Next: AmBase is less a functioning business and more a legal claim attached to a ticker symbol. The company exists solely to fight a protracted legal battle over the 111 West 57th Street property in Manhattan. The cost of capital here is brutal: the CEO gets his principal back first, plus a 1.0x to 3.5x multiple on the funded amount. They are burning cash on lawyers while warning that without favorable legal outcomes or even more expensive capital, the lights go out. It's a binary bet on a New York real estate lawsuit.
What to Watch This Week
Pay attention to the JPMorgan credit facility at XTI Aerospace to see if the bank decides to sweep the collateral. Meanwhile, SITE Centers investors need to track the due bill dates carefully before November 5 to ensure they don't accidentally sell away their right to the $3.00 dividend. See you next week.